Latest & greatest articles for Multinodular Goiter

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Multinodular Goiter or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Multinodular Goiter and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Multinodular Goiter

1. Frailty is More Predictive than Age for Complications After Thyroidectomy for Multinodular Goiter

Frailty is More Predictive than Age for Complications After Thyroidectomy for Multinodular Goiter Frailty Is More Predictive Than Age for Complications After Thyroidectomy for Multinodular Goiter - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S (...) Permalink Copy Page navigation World J Surg Actions . 2020 Feb 12. doi: 10.1007/s00268-020-05422-4. Online ahead of print. Frailty Is More Predictive Than Age for Complications After Thyroidectomy for Multinodular Goiter , , , , , Affiliations Expand Affiliations 1 Department of Surgery, New York Presbyterian Hospital, Weill Cornell Medicine, 525 E 68th Street, F-838, New York, NY, 10065, USA. bmf9002@med.cornell.edu. 2 Department of Surgery, New York Presbyterian Hospital, Weill Cornell Medicine, 525 E

2020 EvidenceUpdates

2. Ten-Year Follow-Up of a Randomized Clinical Trial of Total Thyroidectomy Versus Dunhill Operation Versus Bilateral Subtotal Thyroidectomy for Multinodular Non-toxic Goiter Full Text available with Trip Pro

Ten-Year Follow-Up of a Randomized Clinical Trial of Total Thyroidectomy Versus Dunhill Operation Versus Bilateral Subtotal Thyroidectomy for Multinodular Non-toxic Goiter The aim of this study was to validate in a 10-year follow-up the initial outcomes of various thyroid resection methods for multinodular non-toxic goiter (MNG) reported in World J Surg 2010;34:1203-13.Six hundred consenting patients with MNG were randomized to three groups of 200 patients each: total thyroidectomy (TT (...) ), Dunhill operation (DO), bilateral subtotal thyroidectomy (BST). Obligatory follow-up period of 60 months was extended up to 120 months for all the consenting patients. The primary outcome measure was the prevalence of recurrent goiter and need for revision thyroid surgery. The secondary outcome measure was the cumulative postoperative and post-revision morbidity rate.The primary outcomes were twice as inferior at 10 years when compared to 5-year results for DO and BST, but not for TT. Recurrent goiter

2017 EvidenceUpdates

3. An association of myasthenia gravis with Hashimoto's thyroiditis in a patient with a multinodular goitre Full Text available with Trip Pro

An association of myasthenia gravis with Hashimoto's thyroiditis in a patient with a multinodular goitre The association of myasthenia gravis (MG) with other autoimmune diseases including autoimmune thyroid disease (ATD) is well recognised, although rare. The occurrence of both diseases can occur in two ways: either disease preceding the other, or concurrently. The presentation of MG in association with ATD can range from ocular to generalised disease.A 26-year-old Malay female with persistent (...) hyperthyroidism secondary to Hashimoto's thyroiditis in multinodular goitre was diagnosed with generalised MG after 2 years. She presented with right eye ptosis (ocular) and difficulty in swallowing and chewing (bulbar). The diagnosis of MG was confirmed by fatigability testing, electromyography and the presence of AChR antibodies. Her symptoms showed improvement with pyridostigmine (Mestinon) 60 mg 6-hourly. Her antithyroid drug was tapered down according to her thyroid function test. Throughout a year

2017 Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia

4. Toxic multinodular goitre

Toxic multinodular goitre Toxic multinodular goitre - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Toxic multinodular goitre Last reviewed: February 2019 Last updated: December 2017 Summary Most common in older patients. Onset of symptoms is more insidious and symptoms less dramatic than for Graves' disease. Patients may have apathetic hyperthyroidism (minimal signs/symptoms) or sub-clinical hyperthyroidism (...) (isolated TSH suppression). Spontaneous remission is rare. Definitive treatment, most commonly radioactive iodine, is usually required. If untreated, complications may include sequelae of hyperthyroidism, such as cardiac dysfunction or bone loss, or tracheal compression by large goitres. Definition A toxic multinodular goitre (MNG; also known as Plummer's disease) contains multiple autonomously functioning nodules, resulting in hyperthyroidism. These nodules function independently of thyroid-stimulating

2017 BMJ Best Practice

5. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. Full Text available with Trip Pro

DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. Nontoxic multinodular goiter (MNG) is frequently observed in the general population, but little is known about the underlying genetic susceptibility to this disease. Familial cases of MNG have been reported, and published reports describe 5 families that also contain at least 1 individual with a Sertoli-Leydig cell tumor of the ovary (SLCT). Germline mutations in DICER1, a gene that codes

2011 JAMA